Ordinary Adjustment | Solactive Obesity Index | July 2018

In the ordinary rebalance, the following composition will be implemented:

ABIOMED INC
ANGIODYNAMICS INC
APEX BIOTECHNOLOGY CORP
ARENA PHARMACEUTICALS INC
CARDIOVASCULAR SYSTEMS INC
CATO CORP-CLASS A
CRYOLIFE INC
DAVITA INC
DESTINATION XL GROUP INC
DEXCOM INC
ENDOLOGIX INC
ESPERION THERAPEUTICS INC
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
FRESENIUS MEDICAL CARE AG & CO KGAA
HERBALIFE NUTRITION LTD
INSULET CORP
IRHYTHM TECHNOLOGIES INC
ITAMAR MEDICAL LTD
KERYX BIOPHARMACEUTICALS INC
LEMAITRE VASCULAR INC
LEXICON PHARMACEUTICALS INC
LIFETECH SCIENTIFIC CORP
MADRIGAL PHARMACEUTICALS INC
MANNKIND CORP
MEDIFAST INC
MICROLIFE CORP
MICROPORT SCIENTIFIC CORP
N BROWN GROUP PLC
NIPRO (NISSHO) CORP ORD
NOVO NORDISK AS CLASS B
NUTRISYSTEM INC.
NXSTAGE MEDICAL INC
ORAMED PHARMACEUTICALS INC
RESMED INC-CDI
ROCKWELL MEDICAL INC
SOMNOMED LTD
TAIDOC TECHNOLOGY CORP
USANA HEALTH SCIENCES INC
WEIGHT WATCHERS INTL INC
YPSOMED HOLDING AG
ZAFGEN INC
TANDEM DIABETES CARE INC
RHYTHM PHARMACEUTICALS INC
COHBAR INC
POXEL SA
SENSEONICS HOLDINGS INC
Apollo Endosurgery Inc